Pollack S V
Division of Dermatology, University of Toronto School of Medicine, Ontario, Canada.
J Dermatol Surg Oncol. 1990 Oct;16(10):957-61. doi: 10.1111/j.1524-4725.1990.tb01560.x.
In recent decades, cutaneous surgeons have contributed to the development of a number of implantable materials useful in the management of facial lines and wrinkles. Among these, the most effective are injectable liquid silicone, bovine collagen implant (Zyderm/Zyplast, Collagen Corporation, Palo Alto, CA) and gelatin matrix implant (Fibrel, Mentor Corporation, Goleta, CA). Each of these treatments carries its own balance of efficacy, safety, and ease of use. Clinicians are encouraged to evaluate each of these treatments in order to be able to offer a full range of injectable therapy for the aging face.
近几十年来,皮肤外科医生为开发多种可用于治疗面部皱纹的可植入材料做出了贡献。其中,最有效的是可注射液态硅胶、牛胶原蛋白植入物(Zyderm/Zyplast,胶原蛋白公司,加利福尼亚州帕洛阿尔托)和明胶基质植入物(Fibrel,美敦力公司,加利福尼亚州戈利塔)。这些治疗方法都各有其疗效、安全性和易用性之间的平衡。鼓励临床医生对这些治疗方法逐一进行评估,以便能够为衰老面部提供全方位的注射治疗。